MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 4321-4330 Newer>
The Motley Fool
November 6, 2007
Brian Lawler
The Two Sides of Endo It has been a mixed third quarter for Endo Pharmaceuticals. On the financial side of things the company performed well; on the research and development side, things are not as good. mark for My Articles 45 similar articles
The Motley Fool
November 6, 2007
Brian Lawler
No Surprise That Vertex Has Competition Did shares of Vertex Pharmaceuticals slump on competition concerns? mark for My Articles 161 similar articles
The Motley Fool
November 6, 2007
Brian Orelli
Getting Vaccinated Alongside Mom Merck presents data supporting use of its HPV vaccine in older women. The drugmaker may have a tough marketing job ahead of it. mark for My Articles 365 similar articles
AFP eWire
November 5, 2007
Senate Considering Nonprofit Hospital Reforms Republican staff for the Senate Finance Committee has developed a series of proposed reforms related to governance, meeting community needs and levels of charitable care. mark for My Articles 363 similar articles
The Motley Fool
November 5, 2007
Brian Orelli
Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson. mark for My Articles 22 similar articles
The Motley Fool
November 5, 2007
Brian Orelli
Last Look at Mini-Mylan An impending merger with Merck's KGaA's generic drug business should more than double revenue at Mylan. mark for My Articles 353 similar articles
The Motley Fool
November 5, 2007
Brian Lawler
Encysive in a No-Win Situation Encysive Pharmaceuticals needs help to get its lead drug onto the U.S. market in time to turn its financials around. Investors, take note. mark for My Articles 50 similar articles
The Motley Fool
November 5, 2007
Brian Lawler
Follow the Trend With Novo Nordisk The future is bright for Danish drugmaker Novo Nordisk. The worldwide leader in diabetes treatments turns in another good quarter. mark for My Articles 293 similar articles
The Motley Fool
November 5, 2007
Brian Lawler
King's Abuse-Resistant Bet King Pharmaceuticals signs a development deal with Acura Pharmaceuticals to produce abuse-resistant painkillers. Investors, take note. mark for My Articles 72 similar articles
Managed Care
October 2007
Martin Sipkoff
Asheville's Legacy: Pharmacy Moves From Dispensing to Clinical Management It is an idea whose time has finally come: Today's clinical pharmacists are involved in virtually all aspects of medical care. mark for My Articles 481 similar articles
<Older 4321-4330 Newer>    Return to current articles.